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1. Introduction 
Coupling factor F1 (soluble mitochondrial ATPase) 
plays a key role in the mechanism of oxidative phos- 
phorylation (see reviews [I ,2] ). Factor F, has mol. wt 
approx. 370 000 and contains five types of subunits 
(see reviews [l-4] ). There is no agreement in the 
literature about the subunit stoichiometry and molec- 
ular weight of the subunits. According to Knewles 
and Penefsky [5], whose point of view seems to be 
the most consistent, the molecular weights of the 
subunits of beef heart mitochondrial factor F, are 
54 000 ((Y), 5 1 000 (/3), 33 000 (y), 16 000 (6), and 
11 000 (E), and the subunit composition of a mole- 
cule of the enzyme corresponds to the formula 
OL&Y~E. Knowles and Penefsky [5] have concluded 
that the e-subunit is a dimer of the protein inhibitor 
of mitochondrial ATPase [6] . The results previously 
obtained in our group indicate that the active site of 
mitochondrial ATPase is located on the OL- and/or 
P-subunits [7,8] . 
At first glance it would seem logical that further 
research on the role of the (Y- and &subunits of factor 
F1 in the mechanism of the ATPase reaction should 
be devoted to the study of the structure and catalytic 
properties of isolated subunits. However, as the 
research of Rosing et al. [9] shows, even the ‘mild’ 
dissociation of factor F1 into subunits causes the 
subunits to lose their ability to bind nuclcotides. Thus, 
research connected with the fractionation of factor F, 
into subunits is not very promising in studying the 
role of individual subunits in the mechanism of ATPase 
reaction. In this work we have used another approach. 
Factor F, was treated with ATP y-4-(N-2-chloroethyl- 
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IV-methylamino)benzylamidate, a specific inhibitor 





The subsequent sodium dodecyl sulfate induced dis- 
socation of factor F, into subunits and the separation.of 
the subunits by electrophoresis in polyacrylamide gel 
showed that this ATP derivative binds to the 
P-subunit(s) of factor F1. 
2. Methods 
The soluble mitochondrial ATPase was obtained 
according to Horstman and Racker [lo] . The ATPase 
reaction rate was measured by the pH-metric method 
[ 11,121. For measurement of the ATPase reaction 
rate, the following incubation medium was used: 
3 mM Tris-HCl, pH 8.3,2 mM ATP, 2 mM MgS04 
and factor F1 from lo-40 pg in overall vol. 8 ml. The 
reaction was started by adding factor F, to the reac- 
tion mixture. 
The protein was determined according to Lowry 
et al. [ 131. Electrophoresis of factor F1 in 10% poly- 
acrylamide gel in the presence of dodecyl sulfate was 
carried out by the method of Weber and Osborn [ 141. 
The gels were stained with amido black and scanned 
at 630 nm. 
ATP y-4-(N-2-chloroethyl-N-methylamino)benzyl- 
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amidate [ I.51 was prepared as described in [ 161 . The 
product used for determining the stoichiometry of 
the reaction of factor Fr with this derivative was 
14C-labelled (1 .I mCi/mmol). The 32P-derivative was 
used in experiments to determine the location of the 
active site of mitochondrial ATPase. The radioactivity 
of the preparations possessing a 32P-label was deter- 
mined by measuring the Cerenkov radiation in water. 
Alkylation of the enzyme by the ATP analog was 
studied in a buffer containing 10 mM Tris-HCl, 
pH 7.8 and 0.25 M sucrose. At certain time intervals 
aliquots were taken and added to the incubation medium 
to determine the ATPase activity. 
2. Results and discussion 
At present several modifying reagents are known 
which specifically inhibit soluble mitochondrial 
ATPase, among them 7-chloro4-nitrobenzo-2-oxa- 
1,3-diazol [ 17-191, N-cyclohexyl-N’$-ii4-methyl- 
morpholinium)ethyl carbodiimide [2,20] and mixed 
anhydrides of nucleosidetriphosphates and mesitylen- 
carboxylic acid [21] . All the above-mentioned com- 
pounds suppress the ATPase activity of isolated factor 
Fr , and the inhibition is accompanied by the modifica- 
tion of one of the amino acid residues in the molecule 
of the enzyme. N-cyclohexyl-N’-/3{4-methylmorpho- 
1inium)ethyl carbodiimide and mixed anhydrides of 
nucleosidetriphosphates and mesitylenecarboxylic acid 
probably interact with the amino acid located in the 
active site of the mitochondrial ATPase [2,20,21] 
On the other hand, according to Ferguson et al. [19], 
7-chloro-4-nitrobenzo-2-oxa-1,3-diazol modifies the 
tyrosine residue located outside the active site of 
mitochondrial ATPase. 
In this work we have studied the inhibition of 
soluble mitochondrial ATPase induced by ATP 
y4-(N-2-chloroethyl-N-methyl-amino)benzylamidate, 
the alkylating analog of the ATPase reaction sub- 
strate. Figures 1 and 2 show the dependence of 
factor Fr activity on the time of preincubation with 
this compound. It can be seen that this ATP analog is 
an effective inhibitor of the enzyme. The inhibition 
develops with time, and addition of a fresh portion of 
the inhibitor results in an additional decrease in the 
ATPase reaction rate. The inhibiting effect is increased 
if the preincubation of the enzyme with the ATP 
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Fig.1. Inhibition of soluble mitochondrial ATPase by the 
alkylating ATP analog. At the activity of mitochondrial 
ATPase after 1 min of incubation with the inhibitor at 25°C. 
At the outset, the reaction mixture contained 1 mg/ml of 
factor F,, 10 mM Tris-HCl, pH 7.8, and the ATP analog. 
The concentration of the reagent was 1 mM (l), 2.3 mM 
(2) and 0.90 mM (3). In the last case the mixture was 
supplemented with 10 mM ATP. The arrow shows the second 
addition of freshly prepared reagent (1 mM). 
analog is carried out in the presence of MgS04 (figs 1 
and 2). This result is not unexpected since the Mg 
complexes of nucleotides are more firmly bound to 
the active site of mitochondrial ATPase than free 
nucleotides [22]. 
The suggestion that the inhibiting effect of the ATP 
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Fig.2. Inhibition of soluble mitochondrial ATPase by the 
alkylating analog of ATP in the presence of MgSO,. The reac- 
tion mixture contained 1 mg/ml of factor F, , 10 mM Tris- 
HCI, pH 7.8, the [32P]ATP analog and MgSO,. (1) 0.5 mM 
reagent, 0.5 mM MgSO,, 25’C; (2) 1 mM reagent, 1 mM 
MgSO,, 37°C; (3) 3.3 mM reagent, 3.3 mM MgSO, (37°C). 
Volume 83, number 1 FEBS LETTERS November 1977 
analog is connected with a modification of the active 
site of ATPase is confirmed by the results of the 
experiments in which the reaction between factor F1 
and the inhibitor was carried out in the presence of 
ATP. The ATP, acting as a competitive inhibitor of 
the ATPase reaction in the absence of Mg” [22] , pro- 
tects factor F1 from alkylation, as is exhibited by 
curve 3 (fig.1). The results of experiments with 
4-(N-2-chloroethyl-N-methylamino)benzylamine give 
an additional indication that the alkylating derivative 
of ATP reacts with the active site of factor F,. 
4-(N-2-chloroethyl-N-methylamino)benzylamine in a 
concentration of 2 mM does not inhibit factor F1 
(65 min at 37’C). In its reactivity, this compound 
differs very little from the ATP analog, the rate 
constants for the reaction of chloride liberation under 
comparable conditions being 1 . lo4 s-l and 4 . lo-‘? 
S -‘, respectively [ 15,231. However, the alkylating 
amine does not contain any substrate-like moieties, 
and it is probably for this reason that it does not bind 
to the active site of ATPase. 
At the next stage of investigation we attempted to 
determine the stoichiometry of the reaction-of factor 
F1 with the ATP alkylating analog. For this purpose, 
factor F1 was treated with 0.5 mM [14C]ATP analog 
in the presence of 2 mM MgS04, 10 mM Tris-HCl, 
at 25°C and pH 7.8. /3-Mercaptoethanol up to a con- 
centration of 1% was added to this mixture after 
45 min. The protein containing a radioactive label was 
separated from the free label on a Sephadex G-25 
column. Analysis of the protein fraction showed that 
the radioactive label/factor F1 molar ratio is 1.4 + 0.2. 
If MgS04 is excluded from the reaction mixture, and 
the reaction of factor F1 with the “C-labelled inhibitor 
is carried out in the presence of 10 mM ATP, the radio- 
active label/factor F1 molar ratio drops from 1.4 to 
0.7. Note that 10 mM ATP protects factor F1 com- 
pletely from inactivation by the ATP analog (see fig.1). 
Thus, it seems that the reaction of factor F, with the 
ATP derivative is accompanied by the incorporation 
of two molecules of the inhibitor into each molecule 
of the enzyme. One of the molecules of the ATP 
analog blocks the active site of the enzyme, and the 
other apparently reacts with amino acid residue(s) 
outside the active center. The side reaction does not, 
apparently, cause any changes in the ATPase activity 
of factor F1, nor is it prevented by ATP added to 
alkylation medium. 
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Fig.3. Electrophoresis of factor F, modified by 32P-labelled 
reagent in polyacrylamide gel in the presence of SDS. Factor 
F, treated with 1 mM of the [“P]ATP alkylating analog in 
10 mM Tris-HCl, pH 7.8, at 37°C for 45 min was supplemented 
with mercaptoethanol to a concn. of 1%. The mixture was 
dialysed against 10 mM Tris-HCl and then against distilled 
water. The enzyme separated from the free label was treated 
with 1% sodium dodecylsulfate for 2 h at 37°C. 80 c(g of 
protein were applied on each tube. Electrophoresis was 
carried out in ten tubes simultaneously. Five samples were 
stained with amido black, and the remaining 5 gels were sliced 
into 1 mm thick slices; the slices were placed in separate 
vials and treated with 0.5 ml 0.5 N HCl for 12 h at 35°C. The 
acid was neutralised with 2 N NaOH and the volume was 
brought up to 10 ml with distilled water. The radioactivity of 
each vial was counted for 4 min. In parallel experiments with 
different samples of gel, the position of the radioactivity 
peak varies within 0.5 mm. The solid line represents the 
scanning of gel at 630 nm. The shaded rectangles show the 
radioactivity of the gel slices. 
In the last series of studies it was shown that the 
alkylating analog of ATP reacts preferentially with 
the P-subunit(s) of the enzyme (fig.3). This result 
indicates that the &subunits take part in forming the 
active site of mitochondrial ATPase. 
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